Finally, results of this study along with recently accumulated data clearly prompt us to develop a new scheme of pathology classification as well as risk stratification for patients with neuroblastoma by incorporating the information on the expression of MYC family proteins in conjunction with nuclear morphology of the tumor cells. The gene discussed is MYC; the disease is neoplasm.